Guardion Health Sciences, Inc.

NasdaqCM:GHSI Voorraadrapport

Marktkapitalisatie: US$4.1m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Guardion Health Sciences Beheer

Beheer criteriumcontroles 2/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Jan Hall

Algemeen directeur

US$704.9k

Totale compensatie

Percentage CEO-salaris52.5%
Dienstverband CEO1.3yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn1.3yrs
Gemiddelde ambtstermijn bestuur7.4yrs

Recente managementupdates

Recent updates

Take Care Before Jumping Onto Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even Though It's 39% Cheaper

Sep 22
Take Care Before Jumping Onto Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even Though It's 39% Cheaper

Market Might Still Lack Some Conviction On Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even After 26% Share Price Boost

Jun 06
Market Might Still Lack Some Conviction On Guardion Health Sciences, Inc. (NASDAQ:GHSI) Even After 26% Share Price Boost

Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching

Apr 10
Why Guardion Health Sciences, Inc. (NASDAQ:GHSI) Could Be Worth Watching

Guardion Health Sciences, Inc. (NASDAQ:GHSI) Soars 46% But It's A Story Of Risk Vs Reward

Feb 06
Guardion Health Sciences, Inc. (NASDAQ:GHSI) Soars 46% But It's A Story Of Risk Vs Reward

Market Cool On Guardion Health Sciences, Inc.'s (NASDAQ:GHSI) Revenues

Apr 17
Market Cool On Guardion Health Sciences, Inc.'s (NASDAQ:GHSI) Revenues

Guardion Health Sciences GAAP EPS of -$0.03 beats by $0.01, revenue of $3.27M beats by $0.67M

Aug 11

Guardion Health closes Activ Nutritional acquisition

Jun 02

Guardion Health initiates GlaucoCetin glaucoma trial

May 03

The Guardion Health Sciences (NASDAQ:GHSI) Share Price Has Gained 90% And Shareholders Are Hoping For More

Jan 15
The Guardion Health Sciences (NASDAQ:GHSI) Share Price Has Gained 90% And Shareholders Are Hoping For More

Guardion Health names industry veteran Bret Scholtes as new president and CEO

Dec 28

Is Guardion Health Sciences (NASDAQ:GHSI) In A Good Position To Invest In Growth?

Nov 24
Is Guardion Health Sciences (NASDAQ:GHSI) In A Good Position To Invest In Growth?

Analyse CEO-vergoeding

Hoe is Jan Hall's beloning veranderd ten opzichte van Guardion Health Sciences's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024n/an/a

-US$5m

Mar 31 2024n/an/a

-US$5m

Dec 31 2023US$705kUS$370k

US$158k

Compensatie versus markt: De totale vergoeding ($USD 704.85K ) Jan } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 677.23K ).

Compensatie versus inkomsten: Er zijn onvoldoende gegevens om de beloning van Jan te vergelijken met de prestaties van het bedrijf.


CEO

Jan Hall (65 yo)

1.3yrs

Tenure

US$704,850

Compensatie

Ms. Janet Hall, also known as Jan, serves as Chief Executive Officer and President at Guardion Health Sciences, Inc. since June 19, 2023. She is a highly regarded veteran of big consumer health and consuma...


Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Robert Weingarten
Independent Chairman & Secretary9.3yrsUS$112.60k0.54%
$ 22.2k
Janet Hall
President & CEO1.3yrsUS$704.85kgeen gegevens
Katie Cox
Chief Accounting Officer1.3yrsUS$275.00kgeen gegevens

1.3yrs

Gemiddelde duur

65yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van GHSI wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.3 jaar), wat duidt op een nieuw team.


Bestuursleden

NaamPositieTenureCompensatieEigendom
Robert Weingarten
Independent Chairman & Secretary9.3yrsUS$112.60k0.54%
$ 22.2k
Mark Goldstone
Independent Director9.3yrsUS$75.10k0.27%
$ 11.3k
Donald Gagliano
Independent Director5.5yrsUS$27.60k0.043%
$ 1.8k
Michaela Griggs
Independent Director2.8yrsUS$27.60k0%
$ 0

7.4yrs

Gemiddelde duur

65.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van GHSI wordt beschouwd als ervaren (gemiddelde ambtstermijn 7.4 jaar).